Corporate Mission


At XORTX Pharma Corp., we are dedicated to developing cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy, thereby improving the quality of life and future health of patients.